Vaccination with E743–77-pulsed bm12 mBMDCs resulted in decreased tumor weight and increased infiltrating E7/H2Db tetramer+CD44+CD8+ T cells 22 days after TC-1 inoculation (Figure 2, D, F, and G; gating strategy, and Supplemental Figure 4). Here, CD44 is linked to neoplasm.